Genomics addressed its ethical concerns, AI can do the same - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号)。如果该手机号尚未注册,将自动创建 FT中文网账号。短信可能需要几分钟送达,验证码15分钟内有效,请耐心等待:
请您阅读我们的用户注册协议和隐私权保护政策,点击下方按钮即视为您接受。
FT商学院

Genomics addressed its ethical concerns, AI can do the same

When science is moving faster than legislation, we must stay humble
00:00

{"text":[[{"start":7.26,"text":"The writer is director of the EMBL’s European Bioinformatics Institute"}],[{"start":12.24,"text":"I was lucky enough to be in the engine room of the genomics revolution in the early 2000s. I wrote the software — and co-led the team — that predicted the locations of the genes in the human genome. It was a heady time. New academic departments were magicked into existence, companies with preposterous business plans were founded and wild statements about the future of biology were made. Great science happened — though not always as predicted."}],[{"start":40,"text":"I have not felt the same zeitgeist in science until the recent deepening of AI methods. Once again, there is a transformative technology whose full capabilities we do not know; again, bold companies are striving to make their vision become reality (and reap massive rewards); again, academia is having existential conversations about its role while science moves faster than legislation. And once again, ethical concerns are worrying the public."}],[{"start":67,"text":"Not every aspect is the same. The capital investment in AI is far greater, for example. But I find both reassurance and concern in the similarities."}],[{"start":76.72,"text":"First, reassurance that the scientific step change is real. The AI system AlphaFold’s performance in the protein structure competition was a watershed moment in 2020, but I had already had my head turned by how deep neural networks could tackle biological problems years earlier. The way AI can handle complex data and find effective, non-linear functions to perform certain tasks is near magical (it is a surprisingly trial-and-error process; one has to throw things at the wall and see what sticks). AI offers the opportunity to attack the complexity of biological systems in new ways. We can tackle problems we thought impossible, including modelling multi-morbidity at an individual level, to take one example from my research group."}],[{"start":119.48,"text":"I am sure more “impossible” problems will be solved although it’s foolish to try to predict which — just as we could not predict which parts of biology would be most affected by large-scale DNA sequencing."}],[{"start":129.76,"text":"But just as with genomics, the ethical underpinnings must catch up with what is possible. In the early 2000s those concerns included the privacy of genomic information, gene patenting and the risk of reviving eugenic thinking. Regulators answered them by funding research within the Human Genome Project, formulating responsive ethical assessment schemes and passing anti-discrimination laws. They proved that we first need principles and the ability for regulators to deal with the examples in front of them."}],[{"start":161.82,"text":"My concern is that the hype today is way beyond a reality we don’t fully understand. The claim by some AI leaders that we will cure all human diseases in five years is hubris. We don’t even have good definitions of all diseases, and many of them involve the most complicated object we know in the universe — the human brain. This leaves aside the labour-intensive business of proving that cures work. When glitzy headlines disappoint, the entire field suffers."}],[{"start":190.16,"text":"We don’t need fantastical claims. In uncovering how things work, we must stay humble. From development to infection response to neural circuits leading to behaviours, there are oceans of ignorance in how life works. Large language models will not magic new observations out of the ether. But they do not need to. With the right datasets, domain-specific AIs such as AlphaFold, ChromBPNet, Delphi-2M and others — are cracking open the tough nuts in biology. With human scientists, AI agents and AI generating effective models of the world, there is plenty more insight to be gained."}],[{"start":227.88,"text":"We do not need to justify the role of new technology in biology with outlandish claims. We need to roll up our sleeves, double down on making discoveries of how living things work, share them with the world, and use them to build a more informed, healthier future for all of us."}],[{"start":246.72,"text":""}]],"url":"https://audio.ftcn.net.cn/album/a_1789746574_4646.mp3"}

版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

美国的清晨,市场的黄昏

罗奇:美国中期选举结果再令人震惊,也阻止不了经济金融周期的转向。

共和党为特朗普的失败政策付出代价

特朗普承诺增加制造业就业岗位、提高美国本土出生人口的就业率,但这两项承诺都未兑现。

“鲁珀特不想和失败者为伍”:默多克的媒体帝国对特朗普态度转冷

共和党遭遇失利后,福克斯新闻主持人质疑对伊朗战争的战略,《纽约邮报》则在头版刊出“蓝色海啸”。

Lex专栏:美国选民给数据中心建设热潮降温,未必是坏事

美国中期选举结果可能影响45%的数据中心扩建计划,但对投资者而言,这未尝不是好消息。

英国移民改革:有哪些变化?谁受益?

根据周一公布的改革计划,高收入者及其雇主可能从中受益,但英国也可能因此吓退国际学生。

电力的隐秘力量

能源转型并不像人们让我们以为的那样不可能。
设置字号×
最小
较小
默认
较大
最大
分享×